美時化學製藥股份有限公司
美時化學製藥股份有限公司（Lotus Pharmaceutical Co., Ltd.）在台灣、韓國及國際市場研發製造學名藥。產品組合專注於癌症、中樞神經系統、女性健康及抗肥胖領域。此外提供醫療器材零售與藥物臨床試驗受託業務（CRO）。公司成立於 1966 年，總部位於台灣台北。
今日下跌 1.13%，股價跌破短期均線。該股 RSI(6) 為 34.1，處於中性區間，短線無明顯超買超賣訊號。股價跌破5日、20日、60日、120日均線。短中期均線呈空頭排列，趨勢偏空。KD 指標中性（K=55.4）；MACD 柱狀體為負值，空方動能持續。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 09-24 | -121 | 0 | -26 | -147 |
| 09-23 | +96 | +1 | +4 | +101 |
| 09-22 | +2 | 0 | -6 | -4 |
| 09-21 | -107 | +1 | 0 | -106 |
| 09-18 | -50 | 0 | +1 | -50 |
| 09-17 | +376 | 0 | +2 | +378 |
| 09-16 | -119 | +2 | -12 | -129 |
| 09-15 | +151 | +6 | +18 | +175 |
| 09-14 | +68 | 0 | -26 | +42 |
| 09-11 | -623 | 0 | -8 | -631 |
| 09-10 | -79 | 0 | -15 | -94 |
| 09-09 | -241 | 0 | +13 | -228 |
| 09-08 | -228 | 0 | -12 | -240 |
| 09-07 | -173 | -1 | +3 | -172 |
| 09-04 | -93 | -2 | -2 | -98 |
| 09-03 | -228 | -22 | -6 | -256 |
| 09-02 | -31 | 0 | -9 | -40 |
| 09-01 | -16 | -22 | -18 | -56 |
| 08-31 | -332 | 0 | -13 | -345 |
| 08-28 | -66 | 0 | +18 | -48 |
| 08-27 | -197 | 0 | -99 | -296 |
| 08-26 | +144 | 0 | +21 | +165 |
| 08-25 | +21 | 0 | -81 | -60 |
| 08-24 | -343 | 0 | -23 | -366 |
| 08-21 | +345 | 0 | +18 | +363 |
| 08-20 | +449 | 0 | +71 | +520 |
| 08-19 | +257 | -2 | +33 | +288 |
| 08-18 | +184 | 0 | 0 | +184 |
| 08-17 | +349 | 0 | 0 | +349 |
| 08-14 | -823 | 0 | -48 | -871 |
| 08-13 | +34 | 0 | -1 | +33 |
| 08-12 | -89 | 0 | -13 | -102 |
| 08-11 | +13 | -2 | -3 | +8 |
| 08-10 | +868 | 0 | +51 | +919 |
| 08-07 | +153 | 0 | +18 | +171 |
| 08-06 | +29 | 0 | -10 | +18 |
| 08-05 | +566 | 0 | -20 | +547 |
| 08-04 | -27 | -77 | -67 | -171 |
| 08-03 | +899 | -74 | +27 | +852 |
| 07-31 | -5 | +2 | +21 | +17 |
| 07-30 | +115 | +2 | -19 | +98 |
| 07-29 | +440 | +2 | -4 | +439 |
| 07-28 | -464 | 0 | -60 | -524 |
| 07-27 | +184 | 0 | +4 | +188 |
| 07-24 | -395 | +3 | -2 | -394 |
| 07-23 | -394 | 0 | -63 | -457 |
| 07-22 | +608 | +2 | 0 | +610 |
| 07-21 | +33 | 0 | -65 | -32 |
| 07-20 | +252 | 0 | +24 | +276 |
| 07-17 | -366 | 0 | -84 | -450 |
| 07-16 | -199 | -1 | +9 | -191 |
| 07-15 | +164 | +1 | +15 | +180 |
| 07-14 | -193 | +8 | -30 | -216 |
| 07-13 | -451 | +2 | -124 | -573 |
| 07-09 | -598 | +5 | -58 | -652 |
| 07-08 | -801 | +8 | -109 | -902 |
| 07-07 | +134 | +5 | +90 | +230 |
| 07-06 | +105 | +2 | +12 | +119 |
| 07-03 | +857 | +15 | +189 | +1,061 |
| 07-02 | +215 | +40 | +1 | +256 |
| 07-01 | -83 | -31 | -6 | -121 |
| 06-30 | -269 | 0 | +11 | -258 |
| 06-29 | +449 | -1 | -27 | +422 |
| 06-26 | -545 | 0 | -26 | -572 |
| 06-25 | -909 | -1 | -4 | -914 |
| 06-24 | +378 | 0 | -9 | +369 |
| 06-22 | -236 | 0 | +8 | -227 |
| 06-18 | +161 | -38 | +3 | +126 |
| 06-17 | +267 | -1 | +52 | +318 |
| 06-16 | -445 | -28 | -1 | -474 |
| 06-15 | -265 | -27 | +4 | -288 |
| 06-12 | +650 | -2 | -5 | +643 |
| 06-10 | +484 | +1 | +15 | +501 |
| 06-09 | +142 | +3 | -6 | +139 |
| 06-08 | +429 | +1 | -41 | +389 |
| 06-04 | -108 | 0 | +153 | +46 |
| 06-03 | +99 | -2 | -4 | +93 |
| 06-02 | -133 | +5 | -18 | -146 |
| 06-01 | -28 | +28 | +23 | +24 |
| 05-29 | +18 | 0 | +101 | +119 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/08 | 21.07 億 | -15.4% | +81.7% |
| 2026/07 | 24.92 億 | -26.7% | +3.9% |
| 2026/06 | 33.99 億 | +46.2% | +225.5% |
| 2026/05 | 23.24 億 | -24.7% | +105.8% |
| 2026/04 | 30.86 億 | -29.1% | +19.9% |
| 2026/03 | 43.54 億 | +94.5% | +173.6% |
| 2026/02 | 22.38 億 | +9.1% | +131.5% |
| 2026/01 | 20.52 億 | -16.0% | -5.5% |
| 2025/12 | 24.42 億 | +130.7% | +66.9% |
| 2025/11 | 10.59 億 | -61.5% | -0.2% |
| 2025/10 | 27.53 億 | +126.8% | +46.0% |
| 2025/09 | 12.14 億 | - | +2.2% |